Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
George Kottayil currently holds 12,200 shares of Grace Therapeutics, Inc. (GRCE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George Kottayil has been a net neutral trader of GRCE stock. They have purchased $0 and sold $0 worth of shares.
George Kottayil's most recent insider trade was on Sep 17, 2026, when they sold 12,200 shares at $0.00 per share.
George Kottayil serves as Executive at Grace Therapeutics, Inc. (GRCE). They have executed 2 insider transactions totaling $0 over their tenure at the company.
George Kottayil holds the position of Executive at Grace Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
George Kottayil has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by George Kottayil was on Sep 17, 2026, when they purchased $0 worth of GRCE shares. This transaction involved 12,200 shares at N/A per share.
George Kottayil currently owns 12,200 shares of Grace Therapeutics, Inc. (GRCE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of George Kottayil's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. George Kottayil has 2 Form 4 filings on record as an insider at Grace Therapeutics, Inc..
Set alerts for George Kottayil and 40,000+ other insiders.